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Abstract: Sensory neural hearing loss and vestibular dysfunction have become the most 
common forms of sensory defects, affecting millions of people worldwide. Developing 
effective therapies to restore hearing loss is challenging, owing to the limited regenerative 
capacity of the inner ear hair cells. With recent advances in understanding the 
developmental biology of mammalian and non-mammalian hair cells a variety of strategies 
have emerged to restore lost hair cells are being developed. Two predominant strategies 
have developed to restore hair cells: transfer of genes responsible for hair cell genesis and 
replacement of missing cells via transfer of stem cells. In this review article, we evaluate 
the use of several genes involved in hair cell regeneration, the advantages and 
disadvantages of the different viral vectors employed in inner ear gene delivery and the 
insights gained from the use of embryonic, adult and induced pluripotent stem cells in 
generating inner ear hair cells. Understanding the role of genes, vectors and stem cells in 
therapeutic strategies led us to explore potential solutions to overcome the limitations 
associated with their use in hair cell regeneration. 
OPEN ACCESS
J. Funct. Biomater. 2011, 2 
 
250
Keywords: sensory neural hearing loss; vestibular dysfunction; hair cell regeneration; viral 
vectors; gene delivery; stem cells 
 
1. Introduction 
Hearing loss has become one of the most common disabilities in the United States and can affect 
almost every age group. The number of people with hearing loss worldwide has been steadily 
increasing over recent years, reaching almost 49 million people in the US alone [1]. According to the 
National Institute on Deafness and Other Communication Disorders (NIDCD) 2010 statistics, 
approximately 17% of the American adult population experiences hearing loss and 3 out of every  
1000 children are born deaf. The prevalence of hearing loss increases with age, as about 47% of adults 
over 75 years old have hearing impairment (NIDCD). Although hearing loss may not be life 
threatening, it can greatly influence the patient’s quality of life, social interactions, and have a 
significant financial impact on society [1,2]. 
The ear is of tremendous importance in sensing the world around us. Aside from being the prime 
organ for the perception of sound, it also plays a crucial role in balance. The inner ear is a highly 
specialized sense organ with a complex structure and has been referred to as a labyrinth [3]. It contains 
hair cells arranged in a highly organized pattern and is innervated by sensory neurons. Acoustic 
energy, in the form of sound waves, is channeled into the ear canal where it strikes the tympanic 
membrane. As the energy hits the stapes located at the oval window, a pressure wave sets the cochlear 
fluid into motion. The hair bundles deflect as a result of the shearing force caused by the cochlear fluid 
and the stereocilia slide along one another. The movement on the stereocilia results in their 
depolarization and opens up gated calcium ion channels. This is followed by the release of 
neurotransmitters from the base of the hair cell. Primary auditory afferents then conduct the signal to 
the brainstem. 
Sensorineural hearing loss (SNHL) involves damage to the cochlea (inner ear sensory hair cells) or 
the eighth nerve. It is irreversible and in most cases a hearing aid is required. Common causes for 
SNHL are aging, ototoxic drugs, noise induced trauma, inner ear concussion, and immune  
disorders [4-6]. Although only a small percentage of the cases can be treated medically and surgically, 
advances in molecular and stem cell therapies may provide tools to treat the irreparable damage of hair 
cells caused by SNHL [7]. 
Hair cells are sensory receptors located in the inner ear. They appear to be “hair-like” because of 
the numerous ciliary processes called stereocilia that extend from their surfaces. Hair cells are 
responsible for converting sound into electrical signals that are sent to the brain via the auditory nerve 
for processing. In the human cochlea, hair cell death can occur due to a variety of causes, such as age 
related deafness (presbycusis), a high dosage of ototoxic drugs (e.g., gentamycin, cisplatin, 
aminoglycosides), genetic disorders, infectious diseases, or high levels of noise exposure [3,8,9]. 
Patients exposed to high doses of aminoglycosides as a treatment regimen for bacterial infections often 
experience hair cell death. The aminoglycosides are known to induce cell death via activation of the 
intracellular caspase signaling pathway and trigger mitochondria to release cytochrome c into the 
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cytoplasm, which consequently induces apoptosis via caspase-3 activation in hair cells. Noise induced 
cellular stress activates the JNK signaling pathway and causes neuronal cell death via necrosis. 
Necrotic hair cell death is less common than apoptotic cell death and is mainly induced by trauma or 
disease [3,9,10]. 
Over the past 30 years, several attempts have been made to understand the pathways involved in 
hair cell formation and death [11]. The process of hair cell regeneration was considered impossible to 
occur in higher vertebrates until two groups serendipitously discovered the amazing phenomenon in 
birds in the late 1980s [12]. At the same time, Jørgensen and Mathiesen showed that there were mitotic 
activity and continuous proliferation of hair cells in the vestibular epithelium of adult parakeets [13]. 
Ever since, there has been steady progress in understanding the mechanics and pathways of avian and 
mammalian (rat, mouse, guinea pig) hair cell regeneration [8,10,14-21]. Significant development in 
hair cell regeneration is outlined in the following reviews [7,22-29]. In this review, we explore how 
different genes, viral vectors and stem cell sources can be used in conjunction with each other to 
engineer inner ear hair cells and develop strategies in restoring the function of the inner ear. 
2. Hair Cells, Supporting Cells and Their Function 
2.1. Hair Cells 
Hair cells are the mechanoreceptors in the inner ear that detect sound, head movements and 
orientation in space [9,30]. They are formed in the embryonic stages during the development of the 
inner ear.  The otic ectoderm undergoes proliferation and gives rise to the sensory primordium. The 
proliferating sensory primordium precursors form the organ of corti from within the cochlear 
epithelium and patterns into an organized array of inner and outer hair cells separated from each other 
by non-sensory supporting cells. Hair cells are present in the sensory epithelium of both the auditory 
(inner and outer hair cells) and vestibular systems (Type 1 and Type 2 hair cells). All hair cells are 
surrounded by supporting cells and have physiological and morphological differences. Figure 1 shows 
the classification of inner ear sensory epithelium. Sensory epithelium in the inner ear is composed of 
both sensory and non-sensory cell types that have morphological and physiological differences.  
Table 1 gives the differences between inner and outer hair cells.  
Table 1. Differences between inner and outer hair cells. 
Factor Inner hair cells Outer hair cells Ref. 
Arrangement Arranged in a single row Arranged in three parallel rows [31-33] 
Shape Round and small Long and slim [10] 
Function 
Transduce mechanical energy 
to neural signals 
Appear to impact and regulate 
the sensitivity of the cochlea 
over a range of 32 dB  
[10] 
Effects Sensory Neural Hearing loss 
Alter properties of cochlear 
input to the brain 
[34] 
Approximate number 3,000 to 3,500 9,000 to 12,000 [32,33] 
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Figure 1. Classification of inner ear sensory epithelium. 
 
2.1.1. Hair Cell Structure 
Hair cells are flask-shaped cells with extended processes at their apical ends called stereocilia. The 
stereocilia are made of actin filaments and actin bundling proteins—fimbrin and espin [35]. The 
vestibular system hair cells have one true cilium called the kinocilium that is thought to mark the 
polarity of the cell. Figure 2 shows the schematic representation of a type 2 vestibular hair cell, 
showing the flask-shaped hair cell supported by supporting cells at the base. The stereocilia at the top 
are connected by filamentous tip links that participate in transduction and ion exchange. 
Figure 2. Structure of a typical vestibular hair cell. 
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The kinocilium of cochlear hair cells in mammals degenerates a few weeks after birth [36-40]. Hair 
cells form synaptic connections from neurons at the basal end and terminate in the cochlear or 
vestibular nuclei of the brainstem. The term “mechanoreceptors” comes from their participation in 
transforming mechanical energy to electrical energy. In the auditory system, the mechanical energy 
occurs in the form of a wave and the hair cells are stimulated as the tectorial membrane shears against 
the organ of corti, whereas in the vestibular system, the mechanical energy is a result of displacement 
of hair cells due to the force of gravity or inertia. 
2.1.2. Transduction in Hair Cells 
The stereocilia are connected together by a filamentous tip link. The tips are connected to cation 
transduction channels that are involved in calcium and potassium ion exchange. Each hair cell has 
about 100 transduction channels; the hair cell’s mechanical movement and ion exchange control the 
cell’s membrane potential and provide the driving force for auditory or vestibular nerve excitation. 
Myosin motor proteins are activated by the calcium ions and play an important role in triggering the 
hair cell’s adaptation to mechanical stimuli from stereocilia deflections [11]. 
2.2. Supporting Cells 
Supporting cells are the non-sensory cells of the sensory epithelium and do not take part in sound 
transduction. They are located at the base of the hair cells and surround them, preventing contact 
between individual hair cells. The mammalian auditory system has two main types of supporting cells: 
the Deiter’s cells support the outer hair cells at the base, and the pillar cells help in forming the reticular 
lamina, which isolates the stereocilia from their cell bodies. A few other supporting cells types include 
innerphalangeal cells, Hensen’s cells, Claudius cells and Boettcher cells that are specialized cells and are 
not associated with hair cells [41]. Supporting cells of the vestibular system have yet to be studied in 
detail to understand their physiological and morphological differences [24,30]. Supporting cells are 
known to play an important role in avian hair cell regeneration by two different mechanisms: mitotic 
regeneration and transdifferentiation [42]. The former occurs when the supporting cell divides 
mitotically, stimulating one of them to differentiate into a hair cell, whereas the latter occurs when a 
supporting cell changes its gene expression and becomes a hair cell directly without dividing. Healthy 
supporting cell populations are vital for a number of hair cell regeneration strategies that rely on 
transdifferentiation to restore the damaged neuroeptithelium.  
2.3. Summary 
Hair cells reside in the auditory and vestibular systems and are responsible for mechanoelectrical 
transduction of sound. Ototoxic drugs or noise induced stress can damage hair cells, thus 
compromising inner ear function. Supporting cells located at the base of the hair cells have the 
capability to regenerate hair cells in the vestibular system by mitotic division or transdifferentiation, 
though supporting cell proliferation may not always occur to replace lost hair cells. 
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3. Essential Genes in Hair Cell Differentiation 
It is important to identify and characterize genes that govern the ontogeny and differentiation of the 
cochlear epithelium; identifying such genes can lead to the design of several therapeutic approaches 
for sensory epithelial cell development and hair cell differentiation. A critical gene responsible for 
inner ear development is the Atonal gene—a protein belonging to the basic helix-loop-helix (bHLH) 
family of transcription factors that activates the E-box dependent transcription. Atoh1 has a unique 
auto regulatory enhancer element containing an E-box in the 3’ region of the gene [43]. Math1, also 
known as Atoh1, is the mouse homolog of the Drosophila melanogaster Atonal gene. The Math1 gene 
is essential for the differentiation of sensory hair cells from previously established sensory primordium 
and is limited to only a subpopulation of the non-sensory supporting cells, primarily the pillar  
cells [44,45]. Studies with embryonic Math1-null mice reported a failure to produce hair cells and 
deletion of Atoh1 using Pax2-Cre resulted in degeneration of cells in the organ of corti in mice [46], 
proving Math1 as a positive regulator in directing hair cell differentiation [47]. Gene delivery studies 
in guinea pigs, mice, and rats reported an over expression of Math1 in non-sensory cells, resulting in 
the production of ectopic immature hair cells outside the sensory epithelium via the transdifferentiation 
mechanism [16,44,48-52]. The non-sensory Math1 expressing cells attracted auditory nerve fibers and 
developed into mature hair cells [49,50].  
The other homologues of the Atonal gene are Cath1 (chicken atonal homolog), Xath1 (Xenopus 
atonal homolog) and Hath1 (human atonal homolog), although Math1 is the most extensively studied 
and used transcription factor [53,54]. Studies with adenoviral expression of Hath1 in rats showed hair 
cell production without supporting cell proliferation [55]. 
Additional genes involved in the control of supporting cell fate include Hes1, Hes5, 
BETA2/Neurod1, Jagged2 and Notch Signaling [18,19]. Hes1 and Hes5 have been shown to influence 
supporting cell fate through negative regulation of Math1 [56,57]. Certain cell cycle kinases also 
influence inner ear development by regulating cell cycle and inhibiting hair cell differentiation (Refer 
Table 2). BETA2/Neurod1 gene has been shown to regulate the formation of sensory and neuronal 
ganglions in both cochlear and vestibular systems [58]. Table 2 gives a list of the different genes 
involved in hair cell differentiation. 
Table 2. Summary of different genes used in inner ear gene therapy. 
Gene Role Reference 
Math1 
Also known as Atoh1. Primary gene responsible for 
hair cell differentiation. Other homologues include 
Hath1, Cath1 and Xath1. 
[47,49,53-55] 
Hes1 and Hes5 
Mammalian homologues of Hairy and Enhancer-of-
split gene. Expressed in supporting cells and known 
to be negative regulators of Math1. However, a 
balance between Hes1/Hes5 is required to control 
the production of supernumerary hair cells and 
normal development of inner ear. 
[56,57] 
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Table 2. Cont. 
Gene Role Reference 
Sox2 
Responsible for development of inner ear sensory 
epithelium and is expressed in supporting cells and 
inner ear progenitors. Acts upstream of Math1 and 
maintains mitotic and transdifferentiation functions 
of supporting cells. 
[59-61] 
Jag2 
Member of the notch signaling pathway. Expressed 
in supporting cells of auditory and vestibular 
system. Required for the normal development of 
inner ear sensory organs. 
[19,61,62] 
BETA2/Neurod1 
Expressed in neurons and neural precursor cells. 
Promotes the formation of ganglion neurons in the 
cochlea. Absence of BETA2/NeuroD can 
compromise hair cell function. It is known to 
differentiate outer hair cells to inner ear hair cells 
and neurons to hair cells. 
[58,63] 
Rb1/Rbl2 
Required for hair cell quiescence and cell-cycle exit 
of embryonic mammalian hair cells but not for their 
early differentiation. Deletion of Rb1 from 
progenitor cells leads to aberrant hair cell and 
supporting cell.  Deletion of Rbl2 results in extra 
row of hair cells and supporting cells in apical 




Cyclin-dependent kinase inhibitor. Expressed in 
sensory progenitors during the early embryonic 
development of the cochlea. Regulates cell cycle 
and inhibits hair cell differentiation. 
[69-71] 
MYCN 
Member of the Myc family that regulates 
proliferation. Regulates the growth of the ear as a 
whole and promotes differentiation of certain 
sensory and non-sensory components. Absence of 
MYCN can lead to abnormal development of inner 
ear organs and disorganized neuronal innervations. 
[72] 
Figure 3 represents a schematic on the interaction of different genes and their contribution to 
positive and negative regulation of Math1 transcription factor in neonates and during the embryonic 
development of the cochlea. (A) Hair cells express hair cell-specific Math1 transcription factor and 
notch ligands—Delta1 and Jagged2. Notch receptor (N) binds to the ligands, cleaves with the help of 
γ-secretase and releases Notch Intracellular Domain (NICD). NICD enters the nucleus of supporting 
cells and activated Hes1/Hes5 transcription factors. Hes1/Hes5 proteins inhibit Math1 gene expression. 
Alternatively, expression of Cdkn1b (p27kip1) and Cdkn2d (p19Ink4d) in early progenitor supporting 
cells repress Math1 expression and maintain supporting cell fate. (B) In the presence of  
γ-secretase inhibitors, the notch receptor fails to cleave and release the NICD, thus inhibiting the 
activation of Hes1/Hes5 that would otherwise down regulate Math1 expression. Similarly, targeted 
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deletion of p27kip1 and p19Ink4d genes allows ectopic expression of Math1 resulting in supernumerary 
hair cells. These pathways can be induced or inhibited via standard or molecular therapy and 
additionally can be used to control the differentiation of stem cells. 
Figure 3. Schematic on the interaction of different genes and their contribution to positive 
and negative regulation of Math1 transcription factor. 
 
4. Gene Therapy and Stem Cell-Based Approaches for Treatment of Sensory Neural  
Hearing Loss 
Current therapies for treating hearing loss involve the use of either hearing aids or cochlear 
implants. Cochlear implants are only available to patients with severe hair cell damage and profound 
loss of hearing ability. However, the implants are not absolutely efficient in restoring hearing; their 
performance varies from patient to patient and requires training to adapt to the device. With advances 
in regenerative medicine using stem cells and gene therapy, several new strategies have emerged  
with the hope of permanently curing deafness. Some of these strategies are discussed in the  
following paragraphs. 
4.1. Gene Therapy in the Inner Ear 
A key to modifying cell phenotype is developing an effective means of delivering genes to the inner 
ear. As discussed earlier, the Math1 gene is an essential gene in the differentiation of hair cells. 
Multiple approaches to deliver the Math1 gene into the inner ear have been evaluated. Most of the 
approaches involve the injection of viral or non-viral vectors into the inner ear canal to trigger 
endogenous cells in the organ of corti to differentiate. There are a number of other popular routes of 
vector administration for inner ear gene therapy that are well explained in the literature [73-76]. 
An ideal vector is one that would ensure patient safety and effective transformation of 
undifferentiated cells. The commonly used vectors are derived from adenovirus, adeno-associated 
virus (AAV), herpes virus and lentivirus. Adenoviral mediated Math1 and Hath1 gene delivery has 
shown promising results in vivo for regenerating inner ear hair cells in mammals [16,48,49,51,77]. 
Adenoviral vectors offer high transfection efficiency and have been extensively investigated in clinical 
trials for ocular disease and cystic fibrosis [78,79]. The prior experience with adenovectors in the 
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clinic can make them more desirable for commercial and clinical applications. The efficacy of 
adenoviral vectors can be improved by modifying vector elements, such as using tissue specific 
promoters or deleting DNA sequences to eliminate production of harmful viral proteins. Adenoviral 
mediated vestibular hair cell regeneration has been reported to be more efficient with the glial fibrillary 
acidic protein (GFAP) promoter than the human cytomegalovirus (hCMV) and chicken β actin (cBA) 
promoters. Additionally, adenovectors with deleted E4 regions resulted in increased tolerability of the 
cells toward the vector [51,52,80]. In addition to delivering the Math1 gene, adenoviral vectors are 
used to deliver growth factors such as transforming growth factor-β1 (TGF-β1), glial cell-derived 
neurotrophic factor (GDNF), and B-cell lymphoma 2 (Bcl-2) to protect hair cells from sound trauma 
and ototoxic drugs [81,82]. Despite the success of adenoviruses in the effective delivery of Math1, 
short term gene expression and strong immune responses often result, but can be overcome by  
adeno-associated viruses. Studies show the capacity of adeno-associated viruses to deliver genes to 
inner ear blood vessels and certain auditory nerve fibers with negligible toxicity when compared to 
adenoviruses [76,83]. Herpes simplex viral vectors (HSV) derived from Herpes simplex type I can 
infect and replicate in non-dividing cells. Studies in cochlear gene therapy using HSV reported 
dispersed gene expression in the cochlea, limited to auditory and vestibular spiral ganglion  
neurons [84]. A limitation of HSV mediated gene delivery is that it requires the use of high viral stock 
volumes due to the difficulty of producing the vectors in high titers. In addition, HSV are reported to 
evoke strong inflammatory responses in guinea pigs [85]. Lentivirus is the best available viral vector in 
terms of transduction efficiency and transgene expression because of its ability to infect both 
proliferating and non-proliferating cells, including stem cells that are difficult to transduce. Research 
in lentiviral-mediated gene delivery in the guinea pig cochlea showed gene expression limited to the 
perilymphatic space in the cochlea. High gene expression was observed in ganglion neurons, glial 
cells, and supporting cells; however, the vector failed to infect sensory cells. Although lentiviral 
vectors offer long term gene expression in a variety of cell types, they are known to have a high risk of 
evoking a strong immune response and generating a replication-competent virus [86]. 
Currently, no ideal vector exists for use in inner ear gene delivery. However, adenovector based 
gene therapy is currently the most widely used form of gene therapy in the inner ear. Newer 
recombinant forms of adenoviruses carrying the Math1 gene have shown promising results in 
generating hair cells in both auditory and vestibular systems. Among all known viral vectors, 
adenovirus is widely used in delivering specific genes (Math1, GDNF, and Bcl-2) for regenerating and 
protecting hair cells. Table 3 lists the advantages and disadvantages of using different viral vectors in 
inner ear gene therapy.  
The development and use of different viral vectors in inner ear gene therapy allows us to evaluate 
the effects of introducing specific genes and therapeutic molecules that can regenerate hair cells and 
prevent hair cell damage. 
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Table 3. Summary of different viral vectors used in inner ear gene therapy. 
Vector Advantages Disadvantages Ref. 
Adeno virus 
1) Transfect a wide variety of cell types in the inner ear 
including spiral ganglions, outer hair cells, spiral 
ligament, stria vascularis, and mesenchymal cells in 
both auditory and vestibular systems. 
2) Can produce high titer values that allow injection of 
small dose volumes for gene therapy. 
3) Transgene expression up to 3 weeks can be achieved. 
The short duration of gene expression is ideal for 
hair cell regeneration because prolonged Math1 
expression can produce too many ectopic hair cells 
and compromise hearing. 
4) Effective in delivering Math1 gene to regenerate hair 
cells and Bcl-2 to protect hair cells from damage. 
5) Allows insertion of large DNA segments. 
Recombinant forms can take up to 30kb foreign 
DNA. 
6) Infects dividing and non-dividing cells with very 
high transduction efficiencies, both in vitro and 
in vivo. 
7) Widely researched in clinical studies in both animals 
and humans, giving a better ability to tackle clinical 
complications that can arise. 
1) Evokes a strong host 
immune response. 
2) Does not offer long term 
gene expression. 
3) Entry of the viral vectors is 
largely dependent on a host 
receptor called the 







1) Effectively transfect most inner ear cell types in vivo. 
Studies show transgene expression in cochlear blood 
vessels, nerve fibers and spiral limbus cells. 
2) Effective in targeting stria vascularis and delivering 
tropic factors like NT-3, BDNF, VEGF and FGF. 
3) Transgene expression can occur up to 24 weeks in 
vivo. 
4) Non-toxic to inner ear cells and evokes low immune 
response. 
5) Lacks pathogenicity and has never been associated 
with any known human disease making them suitable 
for clinical applications. 
1) Only effective with in vivo 
inner ear gene therapy. 
2) Successful transgene 
expression in vivo depends 
on route of vector 
administration, limited to 
only direct injection of 
vector. 
3) Previous studies have 
shown possible 
dissemination of vector 
from target tissue. 
4) Offers only a limited 
payload capacity owing to 
its small size. 
5) Risk of insertional 
mutagenesis. 
6) No substantial clinical 
experience. 
7) Vector entry in to host 
largely depends on heparin 
sulfate receptor. 
 [76,89-92]
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Table 3. Cont. 




1) Effectively known to target non-dividing cells, 
specific to nerve cells, spiral ganglion, vestibular 
ganglion and mesenchymal cells in mice and guinea 
pigs. 
2) Newer recombinant vectors offer stable and long 
term gene expression of up to 8 weeks. 
3) Can take large DNA fragments. 
1) Evokes a strong immune 
response. 
2) Transfection is limited only 
to non-dividing neuronal 
cells. 
3) Large size of the virus 
makes it difficult to 
manipulate. 
4) The virus does not integrate 
into the host genome; hence 
gene expression can be 
unstable. 
5) Difficult to produce high 
titer values and requires 
injection of high vector 
volumes. 




1) Transfect both dividing and non-dividing cells, 
including stem cells that are very difficult to 
transfect. 
2) Effectively transduce spiral ganglion neurons and 
supporting cell in vitro. 
3) Studies indicate transgene expression in 
perilymphatic space for up to 2 weeks. 
1) Limited to use in 
production of genes only in 
the perilymph. 
2) Limited dissemination of 
vector and not suitable for 
sensory cell transduction. 
3) Failure to transduce cells in 
the sensory epithelium in 
vivo. 
4) Can randomly integrate into 
host chromosome and 
capable of generating a 
replication competent virus.
5) No clinical experience and 
safety concern arise from 
human immune deficiency 
virus origin. 
[86,94] 
4.2. Stem Cell-Based Therapy for Inner Ear Hair Cell Regeneration 
In situations where the loss of supporting cells may prevent transdifferentiation based regeneration 
strategies, hair cells may be replaced by stem cell therapy. In the last decade, there has been a 
considerable amount of attention directed toward stem cell-based therapies for treating diseases like 
Alzheimer’s, Parkinson’s and cardiovascular diseases. The success of stem cells in treating these 
diseases opened opportunities for researchers to explore the use of stem cells in treating hearing 
disabilities. Stem cell therapy is based on the concept that, upon transplantation, the undifferentiated 
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stem cell has the capacity to respond and react to surrounding cell signals and differentiate into the 
appropriate cell type associated with the signal. Stem cells are a useful way of exploring the molecular 
pathways that underlie hair cell genesis. Some of the stem cell-based therapeutic strategies that have 
employed stem cells in the effort to cure hearing loss are listed below. 
4.2.1. Embryonic Stem Cells 
ESCs are pluripotent and capable of giving rise to cells from any of the three germ layers [95]. With 
respect to hair cell regeneration, it was reported that murine embryonic stem cells can generate inner 
ear progenitors in vitro [96]. These ESCs were allowed to form embryoid bodies and were cultured in 
the presence of epidermal growth factor (EGF), insulin-like growth factor 1 (IGF-1), and basic 
fibroblast growth factor (bFGF). The newly generated progenitor cells were reported to express 
markers characteristic of hair cell differentiation and hair cell specific markers. Additionally, the 
progenitor sensory cells had the capacity to integrate into sensory epithelial layers when injected into 
the developing inner ear of a chicken and to express hair bundle markers in vivo. Another study 
demonstrated the use of murine ESCs from transgenic Math1/nGFP mice [97]. The ESCs were 
differentiated using a step-by-step method toward the ectodermal lineage using otic-inducing growth 
factors. The generated otic progenitor cells had the capacity to develop into mechanosensitive sensory 
hair cells in vitro and demonstrated immature hair cell transduction currents [97]. ESCs have been 
reported to produce sensory auditory neurons and neural progenitors with the potential to restore 
auditory function by generating nerve connections to hair cells [98-100]. Embryoid bodies from 
murine ESCs co-cultured with hair cell explants showed neuron-like cells and positive staining for 
neurofilament [99]. Most of the embryonic stem cell studies have used murine stem cells; however, 
there have been attempts to differentiate human embryonic stem cells (hESCs) in the presence of 
growth factors such as neurotrophin-3 (NT-3), bFGF, BDNF, EGF and bone morphogenic protein 4 
(BMP4). These differentiated cells expressed inner ear and synaptic markers [101-103]. hESCs have 
also been cultured to generate otic progenitors that were capable of differentiating into auditory 
sensory neurons [102].  
Although these studies have demonstrated successful in vitro and in vivo generation of replacement 
hair cells and auditory neurons from ESCs, further investigations are crucial in developing treatment 
strategies for hearing loss because of the controversial and ethical issues linked to ESCs. 
4.2.2. Adult Stem Cells 
Promising results have been shown with bone marrow mesenchymal stem cells (BMSCs) in the 
field of hair cell regeneration. Mesenchymal stem cells derived from rat bone marrow have been 
reported to differentiate into inner ear progenitors and express sensory cell markers including myosin 
VIIa, espin, Brn3c, p27kip and jagged2 in vitro [104]. Additionally, the differentiated cells displayed 
morphological characteristics of hair cell stereociliary bundles. Studies have shown that BMSCs 
stimulated in the presence of growth factors were able to form neuronal progenitors, and after being 
transfected with the Math1 gene, were able to differentiate into inner ear sensory-like cells [104]. 
Adult stem cells also have the potential to deliver gene and therapeutic molecules to other parts of the 
inner ear. For example, Connexin 26, a protein present in cochlear gap junctions and supporting cells 
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was expressed when bone marrow stromal cells were transplanted into the perilymphatic space of the 
mouse cochlea [105]. Bone marrow mesenchymal stem cells also have the potential to differentiate 
into auditory neurons in vitro and in vivo [106,107], demonstrating that a wide variety of inner ear cell 
types can be generated from stem cells. 
Adult stem cells isolated from mouse macular organs have been shown to differentiate into hair 
cells when cultured with EFG and IGF-1 [108]. Adult stem cells isolated from olfactory 
neuroepithelium expressed hair cell markers and resembled hair cells phenotypically when co-cultured 
with cochlear cell supernatant [109]. 
Transplantation studies in mice with bone marrow-derived hematopoietic stem cells (BMHSCs) 
suggested the possibility of differentiation of BMHSCs into mesenchymal cells and fibrocytes in the 
adult inner ear [110]. The results with BMHSCs show their potential to attenuate cochlear injury by 
replacing mesenchymal cells and fibrocytes in the inner ear [110]. 
Adult stem cells from many tissues are now being used to investigate cures for various diseases. 
These cells are not concerned with any ethical issues and can enter clinical trials involving autologous 
transplantation therapies and used in bioengineered products. In treating inner ear disorders, bone 
marrow-derived stem cells have shown the most favorable results [105,106,110,111]. 
4.2.3. Induced Pluripotent Stem Cells 
The discovery of generating induced pluripotent stem cells (iPSCs) introduced a new dimension to 
stem cell research. iPSCs are produced from fibroblasts, other somatic cells and adult stem cells, which 
are reprogrammed to express certain genes and maintain characteristic properties of embryonic stem 
cells. iPSCs opened up the possibility of generating and using patient-specific stem cells without 
immune rejection in vivo and, unlike hESCs, there are no controversial issues associated with their use. 
The most important factors in maintaining the pluripotency of ESC lines are Oct4, c-Myc, Klf4 and 
Sox2. Any adult stem cells forced to express the above four genes under ESC culture conditions can be 
reprogrammed into ESC-like cells [112]. Recently, it was demonstrated that human neural stem cells 
can be directly reprogrammed to iPSCs by just expressing Oct4 [113]. Like ESCs, most studies with 
iPSCs in hair cell regeneration are also of murine origin. A recent study showed generation of iPSCs 
from murine embryonic fibroblasts [97]. These fibroblasts were transduced with retroviruses to 
express Oct4, c-Myc, Klf4 and Sox2. The generated iPSCs were cultured in a medium containing  
otic-inducing FGF-3 and FGF-10 to produce otic progenitor cells. The generated otic progenitors 
differentiated into hair cell-like cells expressing hair cell markers. When co-cultured with  
fibroblast-like cells from embryonic chicken utricles, the differentiated cells developed hair  
bundle-like protrusions, responded to mechanical stimulation, and displayed transduction  
currents [97]. Another study explored the use of iPSCs for restoring auditory ganglion neurons. In 
vitro neuronal differentiation of iPSCs was induced by exposing them to stromal cell-derived inducing 
activity (SDIA). SDIA is a neural inducing activity demonstrated in stromal cells when they 
simultaneously produce inducing and inhibitory factors and was developed by Kawasaki et al. [114]. 
The differentiated cells were transplanted into the cochleas of mice. iPS cell-derived neurons 
projecting toward cochlear hair cells were observed 1 week after transplantation [115]. Although iPS 
cell techniques are novel, researchers have started to explore their potential in treating SNHL. 
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4.2.4. Summary of Stem Cell-Based Therapies 
ESCs have high survival rates and migration capacity when implanted into the cochlea [116,117]. 
They migrated onto auditory neurons and exhibited neuronal differentiation. However, ESCs exhibited 
low integration into endogenous tissue and failed to differentiate completely at the implantation  
site [118,119]. There is also the risk of tumor formation and the risk of transmitting infections with 
ESCs because they use animal products during the culturing process. ESCs used in inner ear treatment 
require the use of immunosuppressive therapy or cloning to avoid graft-vs-host diseases. On the other 
hand, adult stem cells isolated from bone marrow can easily bypass the immune barriers and overcome 
the problem of immune rejection. BMSCs also have a high survival rate and can migrate into multiple 
regions in the cochlea and brain [106,120-122]. Although they can be stimulated to differentiate into a 
number of cell lineages, they differentiate more toward the mesoderm lineage and can be used to 
replace degenerated cochlear fibrocytes [123]. iPSCs do not have any ethical concerns with their use 
and are more patient specific, thus eliminating the risk of immune rejection. Their undifferentiated 
state allows them to migrate to regions surrounding the cochlea. However, one of the major concerns 
with iPSCs is the time required to produce the individual cell lines [124]. They also pose the risk of 
passing on the DNA from the genetically altered cell to future generations.  
Some of the barriers that exist with the use of stem cells are the formation of tumors and  
graft-versus-host diseases. Another concern is the integration of stem cells in the inner ear. Owing to 
the spiral structure of the cochlea, it is challenging to direct the stem cells into the desired location and 
evaluate the integration of differentiated stem cells inside the cochlea. Further investigation with the 
use of different stem cell types and advancements in the existing approaches are necessary before they 
can enter the clinic and begin treating hearing disorders.  
Nevertheless, these concerns bring opportunities for bioengineers and clinicians to engineer cells 
and vectors carrying a combination of genes and therapeutics and develop methods and devices to 
deliver therapeutics at appropriate locations. Recent advances in stem cell technology and gene based 
therapies provide the framework required for the development of potential treatment options. 
5. Discussion 
The success of current approaches unveils the possibility of using different viral vectors, genes, 
growth factors and stem cell types in regenerating inner ear hair cells. Nevertheless, more research is 
still required to overcome challenges involved before these approaches will be ready for clinical and 
commercial use. Although several studies have reported the generation of hair cell-like cells in vitro 
and in vivo (in animals), the outcome and characteristic properties of these cells must be further 
explored. A cell that simply resembles a hair cell morphologically and expresses hair cell markers 
would be immature without being able to respond to mechanical stimuli and transfer signals to the 
auditory neurons. A detailed investigation of their ultra structure and ability to connect to auditory 
neurons and produce transduction currents is essential. In terms of functional outcomes, crucial to any 
tissue engineering strategy, the mechanoelectrical transduction and maturity of transplanted hair  
cell-like cells can be evaluated by auditory brainstem response (ABR) and otoacoustic emissions tests 
(OAE) in animal studies. 
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Audiologists and scientists have come a long way toward reaching the goal for hair cell 
regeneration in mammals by developing inner ear gene therapy strategies in animal models. However, 
an improvement in the existing gene delivery techniques is required to suit clinical applications.  
Some of the drawbacks associated with inner ear gene therapy are addressed below. For example, 
gene delivery studies have shown that over-expression of the Math1 gene led to the formation of 
ectopic hair cells [16,50]. Hair cells are extremely rare and the cochlea contains only about 14,000 hair 
cells that detect and amplify sound [103], and it is important to regulate the cell cycle for normal 
development of cochlear function. Studies in p27kip knockout mice resulted in production of 
supernumerary hair cells and later a massive degradation of the hair cells occurred, leading to a severe 
hearing impairment in these animals. This indicates the importance of precise control of cell  
cycle [69]. There are several pathways that control the expression of Math1 and drive a cell toward 
differentiating into a hair cell. Math1 inhibitors and down regulators can be used in addition to 
targeting the inner ear with only the Math1 gene. This approach can be used to produce an appropriate 
number of hair cells. The activation of a notch receptor can up regulate Hes and Hey genes that are 
potent inhibitors of Math1 [18,19,57]. Inclusion of notch receptor inhibitors in gene therapy can help 
in boosting Math1 gene expression. However, a balance of expression and inhibition between the 
Math1 gene and Math1 inhibitor is required for normal inner ear development and hearing. 
Besides developing strategies to control the expression of the Math1 gene, the side effects caused 
by viral routes also need to be considered. Although viral methods have shown tremendous success in 
the animal model, there is always the risk of DNA mutations and cancer associated with viruses.  
Non-viral gene delivery techniques have recently gained attention due to the minimal risks associated 
in terms of clinical safety and reliability. Another drawback of Math1 gene therapy is that although it 
can be a potential cure for hearing loss caused by sound trauma or ototoxic damage, it may not cure 
hearing loss caused by genetic defects. Stem cell-based therapies in vivo have reported migration of 
these cells into different areas, and thus an ideal route for delivering cells to the right location in the 
cochlea is crucial to restoring hearing loss. The large majority of studies have used only animal models 
and animal stem cells. There is no doubt that these studies have played a major role in gathering 
valuable information about hair cell regeneration; however, the variation among species requires the 
need to explore the use of human stem cell lines like bone marrow derived mesenchymal and 
hematopoietic stem cells, umbilical cord blood and umbilical mesenchymal stromal stem cells, and 
induced pluripotent stem cells. Research in human stem cells lines will have more clinical relevance. 
Gene delivery and stem cells are a potential cure to hearing loss; however, there are limitations that 
must be overcome. Gene therapies must consider using combinations of essential genes and cell cycle 
inhibitors to control the production of hair cells, and detailed quantification of hair cell functionality is 
necessary. Gene delivery vehicles with minimal risk of mutagenesis and immune response must also 
be developed. Finally, an ideal route to implant stem cells inside the cochlea would be essential for 
successful innervations of hair cells, thereby allowing better, if not pristine transmission of sound with 
the assistance of a cochlear implant. 
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